These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2812216)

  • 1. Proteoglycans in the pathogenesis of amyloidosis.
    Linker A
    Neurobiol Aging; 1989; 10(5):507-8; discussion 510-2. PubMed ID: 2812216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses.
    Snow AD; Wight TN
    Neurobiol Aging; 1989; 10(5):481-97. PubMed ID: 2682326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What role(s) may extracellular matrix, particularly heparan sulfate, play in amyloid of Alzheimer's disease.
    Benditt EP
    Neurobiol Aging; 1989; 10(5):506; discussion 510-2. PubMed ID: 2530463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteoglycans, glycosaminoglycans and amyloid deposition.
    Magnus JH; Stenstad T; Husby G
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):575-97. PubMed ID: 7954863
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies--a review.
    Ariga T; Miyatake T; Yu RK
    J Neurosci Res; 2010 Aug; 88(11):2303-15. PubMed ID: 20623617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease.
    Perlmutter LS; Chui HC; Saperia D; Athanikar J
    Brain Res; 1990 Jan; 508(1):13-9. PubMed ID: 2140065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.
    van Horssen J; Otte-Höller I; David G; Maat-Schieman ML; van den Heuvel LP; Wesseling P; de Waal RM; Verbeek MM
    Acta Neuropathol; 2001 Dec; 102(6):604-14. PubMed ID: 11761721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
    Stenstad T; Magnus JH; Husby G
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):663-70. PubMed ID: 7980430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theme and variations on a string of amyloid.
    Kisilevsky R
    Neurobiol Aging; 1989; 10(5):499-500; discussion 510-2. PubMed ID: 2812214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between circulating amyloid fibril protein precursors and extracellular tissue matrix components in the pathogenesis of systemic amyloidosis.
    Husby G; Stenstad T; Magnus JH; Sletten K; Nordvåg BY; Marhaug G
    Clin Immunol Immunopathol; 1994 Jan; 70(1):2-9. PubMed ID: 8261664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of nervous tissue proteoglycans relevant to studies on Alzheimer's disease.
    Margolis RU; Margolis RK
    Neurobiol Aging; 1989; 10(5):500-2; discussion 510-2. PubMed ID: 2530461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
    Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD
    J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's amyloid: is it possible it's not rotten to the core.
    Bartus RT
    Neurobiol Aging; 1989; 10(5):479. PubMed ID: 2812213
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
    Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
    Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential significance of sulphated glycosaminoglycans as a common constituent of all amyloids: or, perhaps amyloid is not a misnomer.
    Kisilevsky R; Snow A
    Med Hypotheses; 1988 Aug; 26(4):231-6. PubMed ID: 3050385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteoglycans and potential mechanisms related to atherosclerosis.
    Berenson GS; Radhakrishnamurthy B; Srinivasan SR; Vijayagopal P; Dalferes ER
    Ann N Y Acad Sci; 1985; 454():69-78. PubMed ID: 3865616
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-surface proteoheparan sulfate structure-function relationships.
    Silbert JE; Gill PJ; Humphries DE; Silbert CK
    Ann N Y Acad Sci; 1989; 556():51-60. PubMed ID: 2525362
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulation of amyloid assembly by glycosaminoglycans: from mechanism to biological significance.
    Quittot N; Sebastiao M; Bourgault S
    Biochem Cell Biol; 2017 Jun; 95(3):329-337. PubMed ID: 28177755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative biochemical analysis of glycosaminoglycans and proteoglycans in human orthotopic and heterotopic bone.
    Mania VM; Kallivokas AG; Malavaki C; Asimakopoulou AP; Kanakis J; Theocharis AD; Klironomos G; Gatzounis G; Mouzaki A; Panagiotopoulos E; Karamanos NK
    IUBMB Life; 2009 Apr; 61(4):447-52. PubMed ID: 19319964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the significance of the binding of proteoglycans to amyloid?
    Caputo CB
    Neurobiol Aging; 1989; 10(5):503-4; discussion 510-2. PubMed ID: 2812215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.